MYND Life Sciences Inc. MYNDF
Set alert
0.01 USD 0.00 0.00%
At close · Oct 30
0.045 Day range 0.0675
0.0081 52-week range 0.0675
- YTD
- 0.00%
- 1 year
- -41.30%
- Open
- 0.045
- Prev close
- 0.0081
- Mkt cap
- 387.32K
- Vol
- 7.92K
- Avg vol
- 0
- EPS
- -0.01
- P/E
- 0.00
More statistics
- Low
- 0.045
- High
- 0.0675
2Y chart
Signals (30)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Jan 7, 2026 | 9 months ago |
| SMA: Bearish | Dec 12, 2025 | 10 months ago |
| SMA: Bearish | Dec 12, 2025 | 10 months ago |
| MACD: Sell Signal | Dec 12, 2025 | 10 months ago |
| RSI: Oversold | Dec 12, 2025 | 10 months ago |
| SMA: Bullish | Dec 3, 2025 | 11 months ago |
| RSI: Overbought | Dec 3, 2025 | 11 months ago |
| MACD: Buy Signal | Sep 29, 2025 | 1 year ago |
| SMA: Bearish | Sep 9, 2025 | 1 year ago |
| SMA: Bearish | Sep 9, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 9, 2025 | 1 year ago |
| RSI: Oversold | Sep 9, 2025 | 1 year ago |
| SMA: Bullish | Sep 8, 2025 | 1 year ago |
| MACD: Buy Signal | Sep 8, 2025 | 1 year ago |
| SMA: Bearish | Jul 31, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 10, 2025 | 1 year ago |
| SMA: Bullish | May 20, 2025 | 1 year ago |
| RSI: Overbought | May 20, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 22, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 27, 2025 | 1 year ago |
| SMA: Bearish | Mar 25, 2025 | 1 year ago |
| SMA: Bullish | Mar 20, 2025 | 1 year ago |
| RSI: Overbought | Mar 20, 2025 | 1 year ago |
| MACD: Buy Signal | Feb 24, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 3, 2025 | 1 year ago |
| SMA: Bearish | Jan 31, 2025 | 1 year ago |
| SMA: Bullish | Jan 21, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 21, 2025 | 1 year ago |
| RSI: Overbought | Jan 21, 2025 | 1 year ago |
| RSI: Oversold | Jan 3, 2025 | 1 year ago |
News
- MYND Life Sciences Announces Shares for Debt Transaction
- MYND Life Sciences Announces the Issuance of 4,000,001 Shares at $0.71/share
- MYND Life Sciences Announces Successful Conclusion of Debenture Settlement Agreement and Leadership Transition
- MYND Life Sciences Announces Strategic Debt Reduction and New Board Member Appointment
- MYND Life Sciences Announces Proposed Share Issuance to Remove Debenture and $3.440 M in debt on business
- MYND Life Sciences Announces New Director & Update on the Proposed Merger with Cava Healthcare Inc.
- MYND Life Sciences Inc. Announces the Appointment of Mr. John Campbell as President and Chief Executive Officer
- Dr. Lyle Oberg Appointment as Board Chair of Alberta Health Services and Executive Chair of MYND Life Sciences
- MYND Life Sciences Inc. Announces Non-Binding LOI to enable merger with Cava Healthcare Inc.
- MYND Life Sciences Announces Update on Payment Obligations Under Unsecured Convertible Debentures
Your note
Sign in to keep a note on MYNDF — it syncs with the Stock Master app.